1. Home
  2. CRIS vs AERT Comparison

CRIS vs AERT Comparison

Compare CRIS & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • AERT
  • Stock Information
  • Founded
  • CRIS 2000
  • AERT 2012
  • Country
  • CRIS United States
  • AERT Singapore
  • Employees
  • CRIS N/A
  • AERT N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • AERT Professional Services
  • Sector
  • CRIS Health Care
  • AERT Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • AERT Nasdaq
  • Market Cap
  • CRIS 32.8M
  • AERT 33.5M
  • IPO Year
  • CRIS 2000
  • AERT N/A
  • Fundamental
  • Price
  • CRIS $3.22
  • AERT $0.61
  • Analyst Decision
  • CRIS Strong Buy
  • AERT
  • Analyst Count
  • CRIS 3
  • AERT 0
  • Target Price
  • CRIS $23.00
  • AERT N/A
  • AVG Volume (30 Days)
  • CRIS 37.6K
  • AERT 70.8K
  • Earning Date
  • CRIS 02-18-2025
  • AERT 02-19-2025
  • Dividend Yield
  • CRIS N/A
  • AERT N/A
  • EPS Growth
  • CRIS N/A
  • AERT N/A
  • EPS
  • CRIS N/A
  • AERT N/A
  • Revenue
  • CRIS $10,259,000.00
  • AERT $72,141,000.00
  • Revenue This Year
  • CRIS N/A
  • AERT N/A
  • Revenue Next Year
  • CRIS N/A
  • AERT N/A
  • P/E Ratio
  • CRIS N/A
  • AERT N/A
  • Revenue Growth
  • CRIS 0.44
  • AERT 16.98
  • 52 Week Low
  • CRIS $2.86
  • AERT $0.51
  • 52 Week High
  • CRIS $17.49
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 47.34
  • AERT 34.83
  • Support Level
  • CRIS $3.05
  • AERT $0.53
  • Resistance Level
  • CRIS $3.55
  • AERT $0.65
  • Average True Range (ATR)
  • CRIS 0.24
  • AERT 0.11
  • MACD
  • CRIS 0.03
  • AERT -0.02
  • Stochastic Oscillator
  • CRIS 47.53
  • AERT 13.90

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: